Non-Participation during Azithromycin Mass Treatment for Trachoma in The Gambia: Heterogeneity and Risk Factors

Non-Participation during Azithromycin Mass Treatment for Trachoma in The Gambia: Heterogeneity and Risk Factors

As the target year for Global Elimination of Trachoma (GET2020) approaches, the scale up of mass drug administration (MDA) with azithromycin will lead to more endemic areas becoming low prevalence settings. In such areas, identification of those at highest risk of Chlamydia trachomatis infection and...

Full description

Bibliographic Details
Main Authors: Edwards, Tansy, Allen, Elizabeth, Harding-Esch, Emma M., Hart, John, Burr, Sarah E., Holland, Martin J., Sillah, Ansumana, West, Sheila K., Mabey, David, Bailey, Robin
Format: Online
Language:English
Published: Public Library of Science 2014
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4148234/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4148234/

Similar Items